₹1,649.40-46.30 (-2.73%)
24-Dec-2025₹1,650.00-37.80 (-2.24%)
24-Dec-2025BSE : 543245
NSE : GLAND
Sector : Health care
ISIN Code : INE068V01023
Last Updated: 24-Dec-2025
| Market Cap (₹ Cr) | 27,182 |
Traded Value (₹ Cr) | 0.72 |
Volume (Shares) | 4,377 |
Face Value (₹) | 1 |
52-Week High (₹) | 2,130.00 |
52-Week High Date | 29-Jul-2025 |
52-Week Low (₹) | 1,200.00 |
52-Week Low Date | 07-Apr-2025 |
All Time High (₹) | 4,350.00 |
All Time High Date | 12-Aug-2021 |
All Time Low (₹) | 861.50 |
All Time Low Date | 22-May-2023 |
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 27,192 |
| EPS - TTM (₹) [C] | 47.97 |
| P/E Ratio (X) [C] | 34.40 |
| Face Value (₹) | 1 |
| Latest Dividend (%) | 1,800.00 |
| Latest Dividend Date | 14-Aug-2025 |
| Dividend Yield (%) | 1.09 |
| Book Value Share (₹) [C] | 580.41 |
| P/B Ratio (₹) [C] | 2.84 |
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| SBI Conservative Hybrid Fund - (IDCW-M) | 53.24 | 3,18,846 | 0.54 |
| SBI Conservative Hybrid Fund - (IDCW-Q) | 53.24 | 3,18,846 | 0.54 |
| SBI Conservative Hybrid Fund - (IDCW-A) | 53.24 | 3,18,846 | 0.54 |
| SBI Conservative Hybrid Fund - (G) | 53.24 | 3,18,846 | 0.54 |
| SBI Conservative Hybrid Fund - Direct (G) | 53.24 | 3,18,846 | 0.54 |
| SBI Conservative Hybrid Fund - Direct (IDCW-A) | 53.24 | 3,18,846 | 0.54 |
| SBI Conservative Hybrid Fund - Direct (IDCW-M) | 53.24 | 3,18,846 | 0.54 |
| SBI Conservative Hybrid Fund - Direct (IDCW-Q) | 53.24 | 3,18,846 | 0.54 |
| SBI Multi Asset Allocation Fund - Direct (G) | 24.56 | 1,47,079 | 0.20 |
| SBI Multi Asset Allocation Fund - Direct (IDCW-A) | 24.56 | 1,47,079 | 0.20 |
Load more
| Date | Broker | Action | Prices(₹) | Report |
|---|---|---|---|---|
| 25-Sep-2025 | Motilal Oswal | Buy | 2,340 | |
| 04-Feb-2025 | Elara Capital | Buy | 1,841 | |
| 06-Nov-2024 | Motilal Oswal | Buy | 1,970 |
| Today's Low/High (₹) | 1,643.60 1,688.20 |
| Week Low/High (₹) | 1,630.50 1,698.00 |
| Month Low/High (₹) | 1,630.50 1,815.00 |
| Year Low/High (₹) | 1,277.80 2,131.00 |
| All time Low/High (₹) | 861.50 4,350.00 |
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | -0.25% | -0.17% | 1.00% | 1.25% |
| 1 Month | -7.88% | -7.87% | 0.60% | 0.70% |
| 3 Month | -16.51% | -16.57% | 4.52% | 4.33% |
| 6 Month | -6.59% | -6.51% | 4.09% | 4.38% |
| 1 Year | -7.30% | -7.27% | 8.84% | 10.18% |
| 3 Year | 4.75% | 4.33% | 42.72% | 46.81% |
Chairman / Executive Director / MD / CEO : SRINIVAS SADU
Independent Non Exe. Director : UDO JAHANNES VETTER
Independent Non Exe. Director : Satyanarayana Murthy Chavali
Independent Non Exe. Director : ESSAJI GOOLAM VAHANVATI
Non-Exec & Non-Independent Dir : Jia Ai (Allen) Zhang
Independent Non Exe. Director : Naina Lal Kidwai
Non-Exec & Non-Independent Dir : Wenjie Zhang
Non-Exec & Non-Independent Dir : Wei Huang
CS / Compliance Officer / Vice President : SAMPATH KUMAR PALLERLAMUDI
Registered Office: Sy No 143-148 150&151 Nr Gandi, X Roads D P Pally Dundigal,Hyderabad,Telangana-500043 Ph: 91-40-30510999
1. What's the Gland Pharma Ltd share price today?
Gland Pharma Ltd share price was Rs 1,649.40 at close on 24th Dec 2025. Gland Pharma Ltd share price was down by 2.73% from the previous closing price of Rs 1,695.70. Gland Pharma Ltd share price trend:
2. How can I quickly analyse the performance of the Gland Pharma Ltd stock?
The performance of the Gland Pharma Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Gland Pharma Ltd?
Gland Pharma Ltd has a market capitalisation of Rs 27,182 crore.
4. What is Gland Pharma Ltd's 52-week high/low share price?
The Gland Pharma Ltd’s 52-week high share price is Rs 2,130.00 and 52-week low share price is Rs 1,200.00.
5. Is the Gland Pharma Ltd profitable?
On a consolidated basis, Gland Pharma Ltd reported a profit of Rs 183.68 crore on a total income of Rs 1,571.04 crore for the quarter ended 2025.
6. Which are Gland Pharma Ltd’s peers in the Health care sector?
Gland Pharma Ltd’s top 5 peers in the Health care sector are Ipca Labs., Ajanta Pharma, J B Chemicals &, Gland Pharma, Emcure Pharma, Piramal Pharma, Wockhardt.
7. Who owns how much in Gland Pharma Ltd?
Key changes to the Gland Pharma Ltd shareholding are as follows: